Each study is 65 patients unevenly between placebo and 25 and 50 mg Proellex distributed . Patients will Proellex Proellex or placebo for 3 months. Additionally reproductions management has contracts for the pivotal studies of Proellex for the indication of chronic treatment of symptomatic uterine fibroids, as well as the large open label safety studies required to chronic use of the drug given support these protocols for the FDA an opinion prior submitted.. One of the soon begin phase III trials will be conducted in 15-20 sites in the U.S. And the second study at several sites ex-US. The tests will consist of three parallel arms each consisting of placebo, 25 and 50 mg Proellex.
Please consult your doctor or other qualified health care provider if you medical condition medical condition, or before taking any drug, changing your diet or commencing or discontinuing the course of treatment. Do not ignore or delay get professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.. Study co-authors were John Booth and Jennifer Pinney , University College London.The authors of the study and editorial reported no financial details.The American Society of Nephrology does not offer medical advice.Continue Reading